Espumil™ Lipophilic foam base
Fagron Advanced Derma Leading advanced dermatological care
With Fagron Advanced Derma, patients offered a total solution for both customized prescription compounding and basic skin care based on:
• Vehicle design according to the latest scientific insights into the tolerance of ingedients used in dermatology • Different bases for different skin types • Suitability for vulnerable, sensitive skin • Optimal compatibility with a broad range of APIs and DCIs • Example formulations are provided for help with prescribing and compounding
Total solution Discover Fagron Advanced Derma’s total solution by accessing the various information resources: Espumil™ foam base • Fagron Advanced Derma brochure • Vehicle brochures Espumil™ foam base is an innovative, lipophilic Benefits of Espumil™ foam base • Compatibility table foam base where the foam is generated by • Innovative base solution for easy • Quality documents unique, foam activating packaging. The unique compounding of foams • Compounding Matters formulations delivery features of Espumil™ foam base • Creamy foam formulation with minimal database allow for the simple application of lipophilic greasiness • Fagron Academy active pharmaceutical ingredients (APIs) and • Light skin feel, drip-free • FACTS (Fagron Academy Compounding dermaceutical ingredients (DCIs) on difficult- • Gentle formulation without gaseous Technical Services) to-treat areas, such as hairy skin and the scalp, propellants; the foam is activated by Fagron’s fagron.us without dripping. Espumil™ foam base is an foam dispenser ideal and stable vehicle for the application of • Often used for application on difficult-to- minoxidil�. Espumil™ foam base is designed treat areas, such as hairy skin and the scalp according to the latest insights into topical • Compatible with lipophilic APIs and DCIs, vehicle safety and maximum solubility such as minoxidil properties for lipophilic APIs and DCIs. • Simple three-step compounding process
1 Geiger CM, Sorenson B, Whaley PA. Stability of minoxidil in Espumil foam base. Int J Pharm Compd. 2013 Mar-Apr;17(2):165-7. Espumil™ foam base foam Espumil™ fagron.us Example Formula. Nocompounded medication isreviewedthe FDA by for safety orefficacy. References available upon request. fromto any any formulationto anythe sameorsimilar whollyor inpart person(includingdeath) is to result that or alleged injury resulting orclaimed responsible for any claims, actions, liabilities, losses, expenses, damages, orcosts judgment orrelated orindirectly arisingdirectly inanyto any way actual this Exampleto Formula.respect Fagron,that Customer understandsandagrees itsowners, Inc., officers, agents, affiliatesnotbe andemployees shall of any formula contained within.Fagron, itsowners, Inc., officers, agents, affiliates andemployees make no representation or warranty whatsoever with Disclaimer: FACTS (Fagron Academy Compounding Technical Services) @fagronacademy.us/facts. Please refer to theCompounding Matters database at fagron.us for more formulations orlearnmore about Espumil™ foam base Example Please refer to theFagron Advanced Dermacompatibility tablefor more vehicle andAPI/DCIcombinations. Example APIsandDCIscompatible withEspumil™ foam base: guarantees maximumpatient comfort for optimalcompliance andresults. Provides continuous care for theskinduringexacerbation andmaintenance phasesand • • Fagron Advanced Dermaoffers a total solution for: Compounding withEspumil™ foam base Melatonin Latanoprost Ketoconazole Finasteride propionateClobetasol Caffeine (17α-estradiol) Alfatradiol API/DCI Tretinoin (vit. Aacid) (vit. Tretinoin Prostaquinon Minoxidil Menthol in Espumil™ foam base foam Espumil™ in 0.1% Finasteride base foam Espumil™ in 5% Minoxidil 0.005% Latanoprost Basic skincare Customized pharmaceutical compounding Above are examples ofsome commonly prescribed formulations across adiverse arrayto encourage ofspecialties, meant the use andisnot
TM Each 0.74 pumpdispensesasingledoseof mL. a foam gaseous withouttheuseof propellants. Available mLsize. in100 Foam-activating packaging to transform Espumil™ foam baseinto Fagron foam dispenser Tel. 423 (800) 6967 -Fax 339 (800) 1596 [email protected] Fagron, -2400 Pilot Knob Inc. Road Paul, -St. Minnesota 55120 - USA compounding formulations for in Espumil™ foam base foam Espumil™ in 3% Prostaquinon™ base foam Espumil™ in Tretinoin 0.05% Aacid) (vit. 5% Minoxidil 0.01 to 0.1% to 0.01 3% 5% 2 to 3%1 to 0.1% to 0.0033 0.005% 2% 0.1% 0.05% 2% 1 to 0.025 to 0.05% Common concentration(s) in Espumil™ foam base foam Espumil™ in Ketoconazole 2% base foam Espumil™ in 5% Minoxidil propionateClobetasol 0.05%
scalp. specific skinareas, skinandthe suchashairy base isidealfor treatment difficult-to-treat of The innovative formulation Espumil™ of foam Espumil Maximum patient comfort with fagron.us 3. 2. 1. method compounding simple three-step Time-saving,
Specific skinarea and dispenseinFagron foam dispenser. Espumil™ foam baseto final weight, mix 50°C).stirring hotplate (max. foam Ifneededuseamagnetic base. therequired¾ of amount Espumil™ of Filter thesolutionandaddsufficient Dissolve APIandDCIinapproximately Calculate andweigh eachingredient. ™ foam base
FADUSes04_0516